Serina Therapeutics Inc (SER)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $37.73M
Last updated: Nov 17, 2026 at 4:10 PM ET
Serina Therapeutics Inc (SER) Stock Chart
Serina Therapeutics (SER) has a latest price of $1.36 on Nov 17, 2026, 68.0% below its 52-week high of $4.26. Its price fell 66.6% over the past 12 months. The month-end price fell 93.3% over the 5 years through Oct 2026, a compound annual decline of 41.8%.
Price Chart
From Nov 2018 to Oct 2026, its highest month-end close was $192.86 in Nov 2018 and its lowest $1.80 in Feb 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SER with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SER.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 49.8%, and over 6 months it fell 15.2%. The month-end price fell 90.9% over the 3 years through Oct 2026, a compound annual decline of 55.1%.
| Period | Change |
|---|---|
| 1 month | -17.3% |
| 3 months | -49.8% |
| 6 months | -15.2% |
| 12 months | -66.6% |
| 12 months, with dividends | -66.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -90.9% | -55.1% |
| 5 years | -93.3% | -41.8% |
Price by Year
Its best calendar year was 2020, when the price fell 16.5%, and its weakest was 2024, when it fell 63.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.94 | +1.4% |
| 2025 | $1.91 | -61.8% |
| 2024 | $5.01 | -63.6% |
| 2023 | $13.75 | -30.2% |
| 2022 | $19.71 | -49.4% |
| 2021 | $38.93 | -28.3% |
| 2020 | $54.29 | -16.5% |
| 2019 | $65.00 | -39.1% |
Trading Range
The price is 27.8% below its 50-day average of $1.89 and 32.0% below its 200-day average of $2.01.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.36 | |
| 52-week high | $4.26 | -68.0% |
| 52-week low | $1.14 | +19.7% |
| 50-day average | $1.89 | -27.8% |
| 200-day average | $2.01 | -32.0% |
Price Risk
Over 3 years, its largest fall from a peak was 94.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.27 |
| Largest fall, 1 year | -70.0% |
| Largest fall, 3 years | -94.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SER
What is SER's 1-year price change?
Serina Therapeutics's price fell 66.6% over the past 12 months. With dividends included, the 12-month total return was -66.6%.
What is SER's 5-year price change?
Serina Therapeutics's month-end price fell 93.3% over the 5 years through Oct 2026, a compound annual decline of 41.8%. These figures leave out dividends.
What is SER's 52-week high and low?
Serina Therapeutics's 52-week high is $4.26 and its 52-week low is $1.14. Its latest price of $1.36 on Nov 17, 2026 is 68.0% below the high.
What is SER's beta?
Serina Therapeutics's 1-year beta against the S&P 500 is 1.27, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 70.0%.
Is the SER chart free?
Yes. Advanced Charting for SER is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SER pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors